You're right on point, and early investors are going to rewarded for their patience.
> Yes, DPWW has debt but so do all startups in OTC.
I had a well-known analyst take a look at DPWW last week, and this is what they had to say about the current volume -
"I think investors are concerned that Diego lacks strength in the balance sheet to sustain the business model through the cannabis market's growing pains. Plus, the company centers its operations in the U.S., which currently limits opportunities due to marijuana being federally classified as a Schedule I drug (I do expect this to change over the long run)."
Every quarter DPWW is better proving their business model, and improving their balance sheet. This is like investing in McDonald's when it was still just an idea.
News 
Market Data 
Discover 
